![Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study - The Lancet Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study - The Lancet](https://www.thelancet.com/cms/attachment/23a959f5-d2e6-4e8d-b1c8-c5bc82de7615/gr1_lrg.gif)
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study - The Lancet
![TIF Position Statement: Demanding Access To Existing And Upcoming Gene Therapies For β-Thalassaemia – TIF TIF Position Statement: Demanding Access To Existing And Upcoming Gene Therapies For β-Thalassaemia – TIF](https://thalassaemia.org.cy/wp-content/uploads/2021/08/Untitled-design-62.png)
TIF Position Statement: Demanding Access To Existing And Upcoming Gene Therapies For β-Thalassaemia – TIF
![Health related quality of life among children with transfusion dependent β- thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study | Health and Quality of Life Outcomes | Full Health related quality of life among children with transfusion dependent β- thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study | Health and Quality of Life Outcomes | Full](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12955-019-1207-9/MediaObjects/12955_2019_1207_Fig3_HTML.png)
Health related quality of life among children with transfusion dependent β- thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study | Health and Quality of Life Outcomes | Full
![Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41434-020-0153-9/MediaObjects/41434_2020_153_Fig1_HTML.png)
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment | Gene Therapy
![Community-wise frequency distribution of β-thalassaemia in Vidarbha... | Download Scientific Diagram Community-wise frequency distribution of β-thalassaemia in Vidarbha... | Download Scientific Diagram](https://www.researchgate.net/publication/272880252/figure/fig2/AS:615063031382031@1523653862598/Community-wise-frequency-distribution-of-b-thalassaemia-in-Vidarbha-region.png)
Community-wise frequency distribution of β-thalassaemia in Vidarbha... | Download Scientific Diagram
![Current and future therapies for beta-thalassemia major. Hemoglobin... | Download Scientific Diagram Current and future therapies for beta-thalassemia major. Hemoglobin... | Download Scientific Diagram](https://www.researchgate.net/profile/Emmanuel-Payen/publication/300419426/figure/fig1/AS:349482052014099@1460334422716/Current-and-future-therapies-for-beta-thalassemia-major-Hemoglobin-disorders-account-for_Q640.jpg)
Current and future therapies for beta-thalassemia major. Hemoglobin... | Download Scientific Diagram
![Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia: Molecular Therapy](https://www.cell.com/cms/attachment/08d4beb7-ced4-4121-a27b-afcdfb311cfe/fx1_lrg.jpg)